In contrast, CRP was found to have no predictive ability for future hypertension in either cohort (Table 3), and was found to be associated with a lower risk of metabolic syndrome in the younger ALSPAC cohort (RR for z‐score increase in logCRP=0.82 [0.71, 0.94]; Table 3). This evidence concerns the gene CRP and metabolic syndrome.